Back
Intra-Cellular Therapies Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
63
ITCI
Intra-Cellular Therapies
Last Price:
89.41
Seasonality Move:
17.18%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Intra-Cellular Therapies Price Quote
$89.41
+0.17 (+0.19%)
(Updated: November 6, 2024 at 5:55 PM ET)
Intra-Cellular Therapies Key Stats
Buy
63
Intra-Cellular Therapies (ITCI)
is a Buy
Day range:
$85.08 - $89.44
52-week range:
$52.88 - $89.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.66
P/B ratio:
8.26%
Volume:
507.2K
Avg. volume:
566.3K
1-year change:
62.28%
Market cap:
$9.5B
Revenue:
$462.2M
EPS:
$-0.87
How Much Does Intra-Cellular Therapies Make?
-
How Much Are Intra-Cellular Therapies's Sales Annually?
ITCI Revenues are $462.2M -
How Much Profit Does Intra-Cellular Therapies's Make A Year?
ITCI net income is -$139.7M
Is Intra-Cellular Therapies Growing As A Company?
-
What Is Intra-Cellular Therapies's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.39% -
What Is Intra-Cellular Therapies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Intra-Cellular Therapies Stock Price Performance
-
Did Intra-Cellular Therapies Stock Go Up Last Month?
Intra-Cellular Therapies share price went up by 22.43% last month -
Did ITCI's Share Price Rise Over The Last Year?
ITCI share price rose by 62.28% over the past 1 year
What Is Intra-Cellular Therapies 52-Week High & Low?
-
What Is Intra-Cellular Therapies’s 52-Week High Share Price?
Intra-Cellular Therapies has traded as high as $89.44 over the past 52 weeks -
What Is Intra-Cellular Therapies’s 52-Week Low Share Price?
Intra-Cellular Therapies has traded as low as $52.88 over the past 52 weeks
Intra-Cellular Therapies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Intra-Cellular Therapies?
-
How Much Debt Does Intra-Cellular Therapies Have?
Total long term debt quarterly is $0 -
How Much Cash Does Intra-Cellular Therapies Have?
Cash and short term investments quarterly total is $1B -
What Is Intra-Cellular Therapies’s Book Value Per Share?
Book value per share is 10.80
Is Intra-Cellular Therapies Cash Flow Positive?
-
What Is ITCI Cash Flow From Operations?
Cash flow from operations (TTM) is -$62.2M -
What Is Intra-Cellular Therapies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $564.9M -
What Is Intra-Cellular Therapies’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$137.8M
Intra-Cellular Therapies Return On Invested Capital
-
Is Management Doing A Good Job?
ITCI return on invested capital is -10.58% -
What Is Intra-Cellular Therapies Return On Assets?
ROA measures how assets are converting to revenues and is -8.93% -
What Is ITCI Return On Equity?
ROE is a measure of profitability and is -10.58%
Intra-Cellular Therapies Earnings Date & Stock Price
-
What Is Intra-Cellular Therapies's Stock Price Today?
A single share of ITCI can be purchased today for 89.24 -
What Is Intra-Cellular Therapies’s Stock Symbol?
Intra-Cellular Therapies trades on the nasdaq under the ticker symbol: ITCI -
When Is Intra-Cellular Therapies’s Next Earnings Date?
The next quarterly earnings date for Intra-Cellular Therapies is scheduled on February 21, 2025 -
When Is ITCI's next ex-dividend date?
Intra-Cellular Therapies's next ex-dividend date is May 26, 2020 -
How To Buy Intra-Cellular Therapies Stock?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Intra-Cellular Therapies Competitors
-
Who Are Intra-Cellular Therapies's Competitors?
Below is a list of companies who compete with Intra-Cellular Therapies or are related in some way:
Intra-Cellular Therapies Dividend Yield
-
What Is ITCI Dividend Yield?
Intra-Cellular Therapies’s dividend yield currently is 0% -
What Is Intra-Cellular Therapies’s Payout Ratio?
Intra-Cellular Therapies’s payout ratio is 0% -
When Did Intra-Cellular Therapies Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Intra-Cellular Therapies’s Dividend Per Share?
Intra-Cellular Therapies pays a dividend of $0.00 per share
Intra-Cellular Therapies Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -27.53% |
| Revenue: | 39.23% | 1.75% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 101.33 |
| Upside from Last Price: | 13.55% |